ARCHIVES

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

NCAB Working Group Appointed To Review NCI Progress

April 30, 2010

NCI Shifts Money to Save 100 Training Slots

July 14, 1989

Aetna No Longer To Cover HDC/BMT For Breast Cancer Outside Of Clinical Trials.

February 25, 2000

NCI Cooperative Group, Cancer Center Trials Listed

September 30, 2005

Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied

July 17, 1992

713 Nurses Pass Certification exam At ONS Congress

July 8, 1988